Showing results (31-40 of 421) with videos related to
Sort By:
Pageof 43
The Journal of Clinical Endocrinology and Metabolism|March 13, 2015
Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomasUrs D Lichtenauer, Guido Di Dalmazi, Emily P Slater, et al.Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Fabry disease - the profile of an orphan disease]Raphaël Tamò, Sandrine A Zweifel, Felix Beuschlein, et al.European Journal of Endocrinology|September 1, 2005
ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivoOliver Zwermann, Dominik M Schulte, Martin Reincke, et al.European Journal of Endocrinology|August 19, 2015
Subclinical hypercortisolism: a state, a syndrome, or a disease?Guido Di Dalmazi, Renato Pasquali, Felix Beuschlein, et al.Gene Expression Patterns : GEP|August 22, 2006
Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal developmentDominik M Schulte, Igor Shapiro, Martin Reincke, et al.European Journal of Endocrinology|November 2, 2005
Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretionNicole Reisch, Marc Slawik, Oliver Zwermann, et al.Oncotarget|October 27, 2015
Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospectsJudith Jakoby, Felix Beuschlein, Susanne Mentz, et al.Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[The basics of lysosomal storage diseases]Raphaël Tamò, Marianne Rohrbach, Matthias Baumgartner, et al.The Journal of Endocrinology|March 13, 2012
Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinomaConstanze Hantel, Felicitas Lewrick, Martin Reincke, et al.Cancer Research|July 9, 2009
Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesisInga K Johnsen, Roland Kappler, Christoph J Auernhammer, et al.Pageof 43